Female infertility. Female infertility
Conditions
Interventions
Intervention 1: For intervention group: A pipelle biopsy to cause endometrial trauma in the day 19th will be performed and superfact 500µg subcutaneously in the day 21st of the menstrual period will b
Treatment - Other
Treatment - Drugs
For intervention group: A pipelle biopsy to cause endometrial trauma in the day 19th will be performed and superfact 500µg subcutaneously in the day 21st of the menstrual period will be administered a
For control group superfact 500µg subcutaneously will be administered in day 21st of the menstrual period and then routine in vitro fertilization will be performed.
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with two or more implantation failure in IVF; to be 18 to 40 years old; not to suffer from any systemic disease such as diabetes, hypertension, etc.) Exclusion criterion: occurrence of intolerable adverse effects.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy. Timepoint: 10 days after in vitro fertilization. Method of measurement: Sending blood sample to laboratory to measure Beta HCG level. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArefe Fakour
Tabriz University of Medical Sciences
Outcome results
None listed